Dr. Miguel-Angel Perales, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Hematologic Malignancies
Studies Blood Cancers
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Miguel-Angel Perales, MD is currently running
Allogeneic T Cell Therapy
for Blood Cancers
The purpose of this study is to evaluate the safety and the efficacy of SMART101 (Human T Lymphoid Progenitor (HTLP)) injection to accelerate immune reconstitution after T cell depleted allogeneic hematopoietic stem cell transplantation (HSCT) in adult and pediatric patients with hematological malignancies.
Recruiting1 award Phase 1 & 2
Cell Therapy
for Non-Hodgkin's Lymphoma
This trial tests a new treatment where a patient's own immune cells are enhanced to fight difficult-to-treat lymphoma. It targets patients whose cancer hasn't responded to at least two other treatments. The modified cells aim to better recognize and attack the cancer. This new method improves the ability of the patient's immune cells to find and destroy cancer cells.
Recruiting1 award Phase 219 criteria
More about Miguel-Angel Perales, MD
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Miguel-Angel Perales, MD has experience with
- Allogeneic Hematopoietic Stem Cell Transplantation
- NEXI-001 T Cell Product
- NEXI-002 T Cells
- Anti-CD19-targeting CAR-T Cells
- Immune Globulin Infusion (Human), 10% Solution
- MB-CART2019.1
Breakdown of trials Miguel-Angel Perales, MD has run
Hematologic Malignancies
Blood Cancers
Myeloid Diseases
Acute Myelogenous Leukemia
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Miguel-Angel Perales, MD specialize in?
Miguel-Angel Perales, MD focuses on Hematologic Malignancies and Blood Cancers. In particular, much of their work with Hematologic Malignancies has involved treating patients, or patients who are undergoing treatment.
Is Miguel-Angel Perales, MD currently recruiting for clinical trials?
Yes, Miguel-Angel Perales, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Miguel-Angel Perales, MD has studied deeply?
Yes, Miguel-Angel Perales, MD has studied treatments such as Allogeneic Hematopoietic Stem Cell Transplantation, NEXI-001 T cell product, NEXI-002 T Cells.
What is the best way to schedule an appointment with Miguel-Angel Perales, MD?
Apply for one of the trials that Miguel-Angel Perales, MD is conducting.
What is the office address of Miguel-Angel Perales, MD?
The office of Miguel-Angel Perales, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.